New Key Statistics Module, Z-Score and F-Score
NAS:SNOA Key Ratios
| Market Cap $ M | 2.42 |
| Enterprise Value $ M | 0.33 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.32 |
| Price/Sales | 0.07 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 12.00 |
| EPS (TTM) $ | -0.94 |
| Beneish M-Score | -2.12 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 44.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.07 |
| EV-to-EBITDA | -0.08 |
| PEG | -- |
| Shares Outstanding M | 15.61 |
| Net Margin (%) | -41.24 |
| Operating Margin % | -36.06 |
| Pre-tax Margin (%) | -41.52 |
| Quick Ratio | 3.11 |
| Current Ratio | 4.07 |
| ROA % (ttm) | -34.16 |
| ROE % (ttm) | -76.57 |
| ROIC % (ttm) | -48.75 |
| Dividend Yield % | -- |
| Altman Z-Score | -17.87 |
SNOA Number of Guru Trades
SNOA Volume of Guru Trades
Gurus Latest Trades with NAS:SNOA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SNOA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sonoma Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SNOA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers